Publication details

Novinky v imunoterapii refrakterní a relabující akutní lymfoblastické leukemie dospělých

Title in English News in the immunotherapy of relapsed and refractory adult acute lymphoblastic leukemia
Authors

HRABOVSKÝ Štěpán FOLBER František DOUBEK Michael

Year of publication 2017
Type Popularization text
MU Faculty or unit

Faculty of Medicine

Citation
Description Acute lymphoblastic leukemia (ALL) is the most common oncological disease in childhood. It is a rare malignancy in the adults. While there are very good treatment achievements in children, the prognosis of adult patients remains unsatisfactory mainly due to a high incidence of treatment-resistant relapses. There is a great progress in both diagnostics and treatment of this disease in past few years, especially thanks to introducing of new drugs into a daily clinical practise. This summary is focused on news in the treatment of relapsed and refractory adult ALL with highlights on immunotherapy.

You are running an old browser version. We recommend updating your browser to its latest version.

More info